RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.6851
-0.0393 (-5.43%)
Sep 8, 2026, 2:45 PM EDT - Market open
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $4.17 million as of September 8, 2026. Its market cap has increased by 145.06% in one year.
Market Cap
4.17M
Enterprise Value
1.27M
1-Year Change
145.06%
Ranking
Category
Stock Price
$0.69
ChartMarket Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $4.17M, a decrease of -92.91%. That is a compound annual growth rate of -17.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.70M | 54.17% |
| Dec 31, 2025 | 2.40M | -69.62% |
| Dec 31, 2024 | 7.90M | 68.09% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
| Jan 7, 2013 | 58.80M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gelteq | 10.07M |
| Sonoma Pharmaceuticals | 6.34M |
| InMed Pharmaceuticals | 6.16M |
| cbdMD | 5.33M |
| Sunshine Biopharma | 4.42M |
| Apimeds Pharmaceuticals US | 3.65M |
| China SXT Pharmaceuticals | 2.95M |
| PRF Technologies | 2.94M |